Breadcrumb

Breadcrumbs

Press Releases

Press Releases

News, Events, Updates, Breakthroughs

Journalists may direct questions to mediainquiries@dsi.com. Or click here for direct contact information for Daiichi Sankyo U.S. Public Affairs team

Press announcements are archived by release date, searchable by topic:

From To
Date Title
Wed May 16 00:00:00 GMT-04:00 2018
Daiichi Sankyo to Present New Data on Multiple Compounds Including Antibody Drug Conjugates DS-8201 ...
PDF (295 KB)
Mon May 14 00:00:00 GMT-04:00 2018
Zymeworks and Daiichi Sankyo Expand Immuno-Oncology Collaboration Focused on Bispecific Antibodies
PDF (171 KB)
Tue May 08 00:00:00 GMT-04:00 2018
Daiichi Sankyo Announces Single Agent Quizartinib Significantly Prolongs Overall Survival Compared ...
PDF (268 KB)
Wed Apr 04 00:00:00 GMT-04:00 2018
Daiichi Sankyo and DarwinHealth Enter Exclusive Research Collaboration for Novel Cancer Target Init ...
PDF (201 KB)
Tue Mar 27 00:00:00 GMT-04:00 2018
Daiichi Sankyo, Inc. and the Crohn’s & Colitis Foundation Launch Get Iron Informed
PDF (226 KB)
Tue Mar 27 00:00:00 GMT-04:00 2018
Daiichi Sankyo's HER2-Targeting Antibody Drug Conjugate DS-8201 Receives SAKIGAKE Designation for G ...
PDF (51 KB)
Wed Mar 07 00:00:00 GMT-04:00 2018
Daiichi Sankyo Initiates Phase 2 Study of DS-8201 in Patients with HER2-Expressing Advanced Colorec ...
PDF (213 KB)
Wed Feb 28 00:00:00 GMT-04:00 2018
Daiichi Sankyo, Inc. Aligns U.S. Commercial Operations to Current Portfolio and Upcoming Cancer Pip ...
PDF (148 KB)
Thu Feb 22 00:00:00 GMT-04:00 2018
Daiichi Sankyo Initiates Phase 1 Study of DS-1062 in Patients with Advanced Non-Small Cell Lung Can ...
PDF (181 KB)
Tue Feb 06 00:00:00 GMT-04:00 2018
Daiichi Sankyo Initiates Phase 1 Study of U3-1402 in Patients with Metastatic EGFR-Mutated Non-Smal ...
PDF (180 KB)
Showing 1 - 10 of 43 results.

Press Release More Stories

More Stories

Who We Are

As the U.S. subsidiary of a global pharmaceutical innovator, Daiichi Sankyo, Inc. draws on a rich heritage of innovation, integrity and accountability..

read more ...